Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
balsam peru + castor oil + trypsin is a topical combination ointment primarily used for the treatment of chronic wounds and skin ulcers, including pressure ulcers (decubitus ulcers), varicose ulcers, and dehisced wounds. The formulation utilizes a triple-action mechanism to facilitate wound healing: **trypsin** acts as a proteolytic enzyme that aids in the debridement of necrotic tissue and eschar by hydrolyzing proteins; **balsam Peru** serves as a mild antiseptic and stimulates the capillary bed to improve local circulation and promote the formation of granulation tissue; and **castor oil** functions as a protective emollient and moisture barrier that prevents wound desiccation and reduces pain. Originally developed by Healthpoint Biotherapeutics (which was later acquired by Smith & Nephew), the product is widely used in clinical settings for wound bed preparation and management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on balsam peru + castor oil + trypsin.